Montrusco Bolton Investments Has Cut Agrium (AGU) Stake, Cardiovascular Systems (CSII)’s Sentiment Is 1.31

June 8, 2017 - By marketbeat

Montrusco Bolton Investments Inc decreased Agrium Inc (AGU) stake by 4.32% reported in 2016Q4 SEC filing. Montrusco Bolton Investments Inc sold 53,670 shares as Agrium Inc (AGU)’s stock declined 10.74%. The Montrusco Bolton Investments Inc holds 1.19 million shares with $119.50 million value, down from 1.24 million last quarter. Agrium Inc now has $12.63B valuation. The stock decreased 1.26% or $1.16 during the last trading session, reaching $90.9. About shares traded. Agrium Inc. (USA) (NYSE:AGU) has risen 5.50% since June 8, 2016 and is uptrending. It has underperformed by 11.20% the S&P500.

Cardiovascular Systems, Inc. is a medical technology company. The company has market cap of $1.02 billion. The Firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. It currently has negative earnings. The Firm develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Montrusco Bolton Investments Inc increased Skyworks Solutions Inc (NASDAQ:SWKS) stake by 17,743 shares to 142,342 valued at $10.60 million in 2016Q4. It also upped Amazon Com Inc (NASDAQ:AMZN) stake by 3,840 shares and now owns 14,594 shares. Qualcomm Inc (NASDAQ:QCOM) was raised too.

Among 21 analysts covering Agrium Inc. (NYSE:AGU), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Agrium Inc. had 52 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was upgraded by Citigroup to “Neutral” on Tuesday, January 5. The rating was maintained by Barclays Capital with “Overweight” on Monday, October 5. The stock of Agrium Inc. (USA) (NYSE:AGU) has “Hold” rating given on Thursday, April 21 by Vertical Research. Canaccord Genuity maintained the shares of AGU in report on Friday, August 7 with “Buy” rating. The firm earned “Neutral” rating on Friday, November 4 by Credit Suisse. On Tuesday, August 11 the stock rating was maintained by RBC Capital Markets with “Outperform”. On Tuesday, January 10 the stock rating was upgraded by Atlantic Securities to “Overweight”. Stifel Nicolaus upgraded the stock to “Hold” rating in Tuesday, May 31 report. The firm has “Hold” rating by Zacks given on Tuesday, September 22. The company was maintained on Thursday, August 18 by Barclays Capital.

Analysts await Agrium Inc. (USA) (NYSE:AGU) to report earnings on August, 9 after the close. They expect $4.47 EPS, up 9.29% or $0.38 from last year’s $4.09 per share. AGU’s profit will be $621.08 million for 5.08 P/E if the $4.47 EPS becomes a reality. After $-0.03 actual EPS reported by Agrium Inc. (USA) for the previous quarter, Wall Street now forecasts -15,000.00% EPS growth.

Analysts await Cardiovascular Systems Inc (NASDAQ:CSII) to report earnings on August, 2. They expect $-0.02 EPS, up 86.67% or $0.13 from last year’s $-0.15 per share. After $0.03 actual EPS reported by Cardiovascular Systems Inc for the previous quarter, Wall Street now forecasts -166.67% negative EPS growth.

Perkins Capital Management Inc holds 3.39% of its portfolio in Cardiovascular Systems Inc for 127,550 shares. Camber Capital Management Llc owns 2.50 million shares or 3.15% of their US portfolio. Moreover, Ironwood Investment Management Llc has 1.15% invested in the company for 64,903 shares. The Minnesota-based Next Century Growth Investors Llc has invested 0.98% in the stock. Granahan Investment Management Inc Ma, a Massachusetts-based fund reported 1.16 million shares.